Industry: Electronics & Semiconductor
Published Date: 2024-02-07
Pages: 114 Pages
Report ld: 2463313
Request Sample
Customized Report
Hybrid Brain–Computer Interface (hBCI) Market Size(US$)

CAGR 2024-2030
5.2%
Market Size,2030
USD 599.1
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
A typical hybrid BCI is also composed of one BCI and another system (which might be another BCI), and must also achieve specific goals better than a conventional system. For example, a hybrid BCI might infer user intent more accurately during imagery-based and/or visual attention-based experimental paradigms, improve the overall performance of the system, or reduce the rate of false positives during resting periods of i.e. steady-state visual evoked potential (SSVEP)-based BCI applications.
The global Hybrid Brain–Computer Interface (hBCI) market was valued at US$ 426 million in 2023 and is anticipated to reach US$ 599.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
North American market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hybrid Brain–Computer Interface (hBCI) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hybrid Brain–Computer Interface (hBCI) include Neuralink, NeuroSky, NeuroPace, EMOTIV, Blackrock Neurotech, Compumedics, Advanced Brain Monitoring, G.TEC and Neuroelectrics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hybrid Brain–Computer Interface (hBCI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hybrid Brain–Computer Interface (hBCI).
MARKET SEGMENTATION
REPORT SCOPE
The Hybrid Brain–Computer Interface (hBCI) market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hybrid Brain–Computer Interface (hBCI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hybrid Brain–Computer Interface (hBCI) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hybrid Brain–Computer Interface (hBCI) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Hybrid Brain–Computer Interface (hBCI) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Hybrid Brain–Computer Interface (hBCI) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Hybrid Brain–Computer Interface (hBCI) Market Overview
1.1 Product Definition
1.2 Hybrid Brain–Computer Interface (hBCI) Segment by Type
1.2.1 Global Hybrid Brain–Computer Interface (hBCI) Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Invasive
1.2.3 Non-invasive
1.3 Hybrid Brain–Computer Interface (hBCI) Segment by Application
1.3.1 Global Hybrid Brain–Computer Interface (hBCI) Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Healthcare
1.3.3 Entertainment and Education
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Hybrid Brain–Computer Interface (hBCI) Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Hybrid Brain–Computer Interface (hBCI) Production Estimates and Forecasts (2019-2030)
1.4.4 Global Hybrid Brain–Computer Interface (hBCI) Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Manufacturers (2019-2024)
2.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Hybrid Brain–Computer Interface (hBCI), Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Hybrid Brain–Computer Interface (hBCI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Hybrid Brain–Computer Interface (hBCI) Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Hybrid Brain–Computer Interface (hBCI), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Hybrid Brain–Computer Interface (hBCI), Product Offered and Application
2.8 Global Key Manufacturers of Hybrid Brain–Computer Interface (hBCI), Date of Enter into This Industry
2.9 Hybrid Brain–Computer Interface (hBCI) Market Competitive Situation and Trends
2.9.1 Hybrid Brain–Computer Interface (hBCI) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Hybrid Brain–Computer Interface (hBCI) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Hybrid Brain–Computer Interface (hBCI) Production by Region
3.1 Global Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Region (2019-2030)
3.2.1 Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Hybrid Brain–Computer Interface (hBCI) by Region (2025-2030)
3.3 Global Hybrid Brain–Computer Interface (hBCI) Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Hybrid Brain–Computer Interface (hBCI) Production by Region (2019-2030)
3.4.1 Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Hybrid Brain–Computer Interface (hBCI) by Region (2025-2030)
3.5 Global Hybrid Brain–Computer Interface (hBCI) Market Price Analysis by Region (2019-2024)
3.6 Global Hybrid Brain–Computer Interface (hBCI) Production and Value, Year-over-Year Growth
3.6.1 North America Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2019-2030)
3.6.5 South Korea Hybrid Brain–Computer Interface (hBCI) Production Value Estimates and Forecasts (2019-2030)
4 Hybrid Brain–Computer Interface (hBCI) Consumption by Region
4.1 Global Hybrid Brain–Computer Interface (hBCI) Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Hybrid Brain–Computer Interface (hBCI) Consumption by Region (2019-2030)
4.2.1 Global Hybrid Brain–Computer Interface (hBCI) Consumption by Region (2019-2024)
4.2.2 Global Hybrid Brain–Computer Interface (hBCI) Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Hybrid Brain–Computer Interface (hBCI) Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Hybrid Brain–Computer Interface (hBCI) Production by Type (2019-2030)
5.1.1 Global Hybrid Brain–Computer Interface (hBCI) Production by Type (2019-2024)
5.1.2 Global Hybrid Brain–Computer Interface (hBCI) Production by Type (2025-2030)
5.1.3 Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Type (2019-2030)
5.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Type (2019-2030)
5.2.1 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Type (2019-2024)
5.2.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Type (2025-2030)
5.2.3 Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Type (2019-2030)
5.3 Global Hybrid Brain–Computer Interface (hBCI) Price by Type (2019-2030)
6 Segment by Application
6.1 Global Hybrid Brain–Computer Interface (hBCI) Production by Application (2019-2030)
6.1.1 Global Hybrid Brain–Computer Interface (hBCI) Production by Application (2019-2024)
6.1.2 Global Hybrid Brain–Computer Interface (hBCI) Production by Application (2025-2030)
6.1.3 Global Hybrid Brain–Computer Interface (hBCI) Production Market Share by Application (2019-2030)
6.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Application (2019-2030)
6.2.1 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Application (2019-2024)
6.2.2 Global Hybrid Brain–Computer Interface (hBCI) Production Value by Application (2025-2030)
6.2.3 Global Hybrid Brain–Computer Interface (hBCI) Production Value Market Share by Application (2019-2030)
6.3 Global Hybrid Brain–Computer Interface (hBCI) Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Neuralink
7.1.1 Neuralink Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.1.2 Neuralink Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.1.3 Neuralink Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Neuralink Main Business and Markets Served
7.1.5 Neuralink Recent Developments/Updates
7.2 NeuroSky
7.2.1 NeuroSky Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.2.2 NeuroSky Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.2.3 NeuroSky Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.2.4 NeuroSky Main Business and Markets Served
7.2.5 NeuroSky Recent Developments/Updates
7.3 NeuroPace
7.3.1 NeuroPace Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.3.2 NeuroPace Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.3.3 NeuroPace Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.3.4 NeuroPace Main Business and Markets Served
7.3.5 NeuroPace Recent Developments/Updates
7.4 EMOTIV
7.4.1 EMOTIV Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.4.2 EMOTIV Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.4.3 EMOTIV Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.4.4 EMOTIV Main Business and Markets Served
7.4.5 EMOTIV Recent Developments/Updates
7.5 Blackrock Neurotech
7.5.1 Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.5.2 Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.5.3 Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Blackrock Neurotech Main Business and Markets Served
7.5.5 Blackrock Neurotech Recent Developments/Updates
7.6 Compumedics
7.6.1 Compumedics Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.6.2 Compumedics Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.6.3 Compumedics Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Compumedics Main Business and Markets Served
7.6.5 Compumedics Recent Developments/Updates
7.7 Advanced Brain Monitoring
7.7.1 Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.7.2 Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.7.3 Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Advanced Brain Monitoring Main Business and Markets Served
7.7.5 Advanced Brain Monitoring Recent Developments/Updates
7.8 G.TEC
7.8.1 G.TEC Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.8.2 G.TEC Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.8.3 G.TEC Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.8.4 G.TEC Main Business and Markets Served
7.7.5 G.TEC Recent Developments/Updates
7.9 Neuroelectrics
7.9.1 Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.9.2 Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.9.3 Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Neuroelectrics Main Business and Markets Served
7.9.5 Neuroelectrics Recent Developments/Updates
7.10 Brain Products
7.10.1 Brain Products Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.10.2 Brain Products Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.10.3 Brain Products Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Brain Products Main Business and Markets Served
7.10.5 Brain Products Recent Developments/Updates
7.11 ANT Neuro
7.11.1 ANT Neuro Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.11.2 ANT Neuro Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.11.3 ANT Neuro Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.11.4 ANT Neuro Main Business and Markets Served
7.11.5 ANT Neuro Recent Developments/Updates
7.12 BrainCo
7.12.1 BrainCo Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.12.2 BrainCo Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.12.3 BrainCo Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.12.4 BrainCo Main Business and Markets Served
7.12.5 BrainCo Recent Developments/Updates
7.13 Neuracle
7.13.1 Neuracle Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.13.2 Neuracle Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.13.3 Neuracle Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Neuracle Main Business and Markets Served
7.13.5 Neuracle Recent Developments/Updates
7.14 Flexolink
7.14.1 Flexolink Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.14.2 Flexolink Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.14.3 Flexolink Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Flexolink Main Business and Markets Served
7.14.5 Flexolink Recent Developments/Updates
7.15 NeuralFlex
7.15.1 NeuralFlex Hybrid Brain–Computer Interface (hBCI) Corporation Information
7.15.2 NeuralFlex Hybrid Brain–Computer Interface (hBCI) Product Portfolio
7.15.3 NeuralFlex Hybrid Brain–Computer Interface (hBCI) Production, Value, Price and Gross Margin (2019-2024)
7.15.4 NeuralFlex Main Business and Markets Served
7.15.5 NeuralFlex Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Hybrid Brain–Computer Interface (hBCI) Industry Chain Analysis
8.2 Hybrid Brain–Computer Interface (hBCI) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Hybrid Brain–Computer Interface (hBCI) Production Mode & Process
8.4 Hybrid Brain–Computer Interface (hBCI) Sales and Marketing
8.4.1 Hybrid Brain–Computer Interface (hBCI) Sales Channels
8.4.2 Hybrid Brain–Computer Interface (hBCI) Distributors
8.5 Hybrid Brain–Computer Interface (hBCI) Customers
9 Hybrid Brain–Computer Interface (hBCI) Market Dynamics
9.1 Hybrid Brain–Computer Interface (hBCI) Industry Trends
9.2 Hybrid Brain–Computer Interface (hBCI) Market Drivers
9.3 Hybrid Brain–Computer Interface (hBCI) Market Challenges
9.4 Hybrid Brain–Computer Interface (hBCI) Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Hybrid Brain–Computer Interface (hBCI) was estimated to be worth US$ 484 million in 2025 and is projected to reach US$ 687 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 118
USD 3950.00
(Single User License)
The global Hybrid Brain–Computer Interface (hBCI) market was valued at US$ 484 million in 2025 and is anticipated to reach US$ 687 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 139
USD 2900.00
(Single User License)
The global Hybrid Brain–Computer Interface (hBCI) market is projected to grow from US$ 463 million in 2024 to US$ 657 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 164
USD 4900.00
(Single User License)
The global Hybrid Brain–Computer Interface (hBCI) market size was US$ 463 million in 2024 and is forecast to a readjusted size of US$ 657 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 96
USD 4250.00
(Single User License)
The global market for Hybrid Brain–Computer Interface (hBCI) was estimated to be worth US$ 463 million in 2024 and is forecast to a readjusted size of US$ 657 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 118
USD 3950.00
(Single User License)
The global market for Hybrid Brain–Computer Interface (hBCI) was valued at US$ 463 million in the year 2024 and is projected to reach a revised size of US$ 657 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-02-14
Pages: 98
USD 2900.00
(Single User License)
A typical hybrid BCI is also composed of one BCI and another system (which might be another BCI), and must also achieve specific goals better than a conventional system. For example, a hybrid BCI might infer user intent more accurately during imagery-based and/or visual attention-based experimental paradigms, improve the overall performance of the system, or reduce the rate of false positives during resting periods of i.e. steady-state visual evoked potential (SSVEP)-based BCI applications.
Published Date: 2024-04-19
Pages: 114
USD 4900.00
(Single User License)
The global market for Hybrid Brain–Computer Interface (hBCI) was estimated to be worth US$ 484 million in 2025 and is projected to reach US$ 687 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-02-02
Pages: 118
The global Hybrid Brain–Computer Interface (hBCI) market was valued at US$ 484 million in 2025 and is anticipated to reach US$ 687 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-02-02
Pages: 139
The global Hybrid Brain–Computer Interface (hBCI) market is projected to grow from US$ 463 million in 2024 to US$ 657 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 164
The global Hybrid Brain–Computer Interface (hBCI) market size was US$ 463 million in 2024 and is forecast to a readjusted size of US$ 657 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 96
The global market for Hybrid Brain–Computer Interface (hBCI) was estimated to be worth US$ 463 million in 2024 and is forecast to a readjusted size of US$ 657 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 118
The global market for Hybrid Brain–Computer Interface (hBCI) was valued at US$ 463 million in the year 2024 and is projected to reach a revised size of US$ 657 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-02-14
Pages: 98
A typical hybrid BCI is also composed of one BCI and another system (which might be another BCI), and must also achieve specific goals better than a conventional system. For example, a hybrid BCI might infer user intent more accurately during imagery-based and/or visual attention-based experimental paradigms, improve the overall performance of the system, or reduce the rate of false positives during resting periods of i.e. steady-state visual evoked potential (SSVEP)-based BCI applications.
Published: 2024-04-19
Pages: 114
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now